Brandes Investment Partners’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $3.9M | Sell |
|
|||||
|
2023
Q3 | $17.9M | Buy |
|
|||||
|
2023
Q2 | $16.4M | Buy |
|
|||||
|
2023
Q1 | $15.5M | Buy |
|
|||||
|
2022
Q4 | $12.2M | Sell |
|
|||||
|
2022
Q3 | $12.4M | Buy |
|
|||||
|
2022
Q2 | $20.6M | Buy |
|
|||||
|
2022
Q1 | $21.4M | Sell |
|
|||||
|
2021
Q4 | $31.3M | Sell |
|
|||||
|
2021
Q3 | $37.5M | Sell |
|
|||||
|
2021
Q2 | $30.7M | Buy |
|
|||||
|
2021
Q1 | $20.1M | Buy |
|
|||||
|
2020
Q4 | $12.3M | Buy |
|
|||||
|
2020
Q3 | $6.58M | Buy |
|
|||||
|
2020
Q2 | $340K | Sell |
|
|||||
|
2020
Q1 | $6.93M | Buy |
|
|||||
|
2019
Q4 | $312K | Buy |
|
|||||
|
2019
Q3 | $290K | Sell |
|
|||||
|
2019
Q2 | $412K | Sell |
|
|||||
|
2019
Q1 | $1.11M | Buy |
|
|||||
|
2018
Q4 | $858K | Buy |
|
|||||
|
2018
Q3 | $254K | Sell |
|
|||||
|
2018
Q2 | $907K | Sell |
|
|||||
|
2018
Q1 | $1.33M | Buy |
|